![Beth Hoffman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: - $ am 30.06.2026
Beth J.
Hoffman is the founder of Origami Therapeutics, Inc., founded in 2015, where the title held is President & Chief Executive Officer.
Dr. Hoffman currently holds the position of Independent Director at Biofrontera, Inc., starting in 2015.
Dr. Hoffman earned a doctorate degree from The Johns Hopkins University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOFRONTERA, INC. -.--% | 04.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOFRONTERA INC. | Direktor/Vorstandsmitglied | 03.03.2015 |
Origami Therapeutics, Inc.
 Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Vorstandsvorsitzender | 01.01.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera, Inc.
 Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
